The global peripheral vascular devices market, valued at USD 4.7 billion in 2022, is projected to expand at a robust CAGR of 6.6%, reaching USD 8.9 billion by 2032, according to Future Market Insights ...

R3 Vascular announced that a doctor treated the first patient in the ELITE-BTK pivotal trial of its drug-eluting ...

A case-based discussion navigates the decision-making process for a patient with chronic limb-threatening ischemia with poor ...

China: A recent case series published in BMC Surgery has highlighted the potential of the Willis covered stent (WCS) as a ...

The coronary stent market in the Asia-Pacific (APAC) region is witnessing sustained growth, driven by rising coronary artery ...

The procedure involves inserting a next-generation bioresorbable stent through a fine catheter in the thigh ...

The global coronary stents market is expected to experience robust growth over the next decade, surging from an estimated USD 35.5 billion in 2025 to a projected USD 57.9 billion by 2035. This ...

During stenting for ICAS, eight patients (male ... Inadequate tissue perfusion downstream of the targeted arterial segment; (4) Having at least one risk factor for atherosclerosis; 5) At least 3 weeks ...

Background The vertebral artery (VA) ostium (VAO) is a common stenosis site. Most patients with VAO stenosis refractory to medical treatment are treated endovascularly using stenting. To optimally ...

New Delhi: Through a recent notification, after considering the Wholesale Price Index (WPI) @ 1.74028% for the year 2024 over 2023, the National Pharmaceutical Pricing Authority (NPPA) has revised and ...

The National Pharmaceutical Pricing Authority (NPPA) has allowed manufacturers and importers to increase the prices of coronary stents to reflect the rise in inflation. In an order dated March 27 ...